U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07947966) titled 'Safety and Drug Concentrations of REGN20566 in Adults With Overweight or Obesity' on Nov. 13.

Brief Summary: This study will test a Regeneron drug called REGN20566 ("study drug") to see how safe it is and how participants with overweight or obesity respond to it.

The study will be split into two parts, Part A and Part B.

The study is looking at:

* What side effects REGN20566 might cause

* How much REGN20566 is in the blood at different times

* If the body reacts to REGN20566 in a way that may cause REGN20566 to not work as well

Study Start Date: Dec. 14

Study Type: INTERVENTIONAL

Condition: Overweight Obesity

Intervention:...